461 results on '"Baldacci S"'
Search Results
2. Single breath nitrogen test as predictor of lung function decline and COPD over an 8-year follow-up
3. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGFR: Therapeutic algorithm of EGFR mutation driven advanced non-small cell carcinoma
4. Issue 1 - “Update on adverse respiratory effects of outdoor air pollution”. Part 1): Outdoor air pollution and respiratory diseases: A general update and an Italian perspective
5. Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study
6. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGFR
7. Oncogenèse pulmonaire : de l’altération moléculaire au cancer
8. Traitement des cancers bronchiques non à petites cellules de stades avancés mutés EGFR: quelle(s) séquence(s) ?
9. Prise en charge diagnostique et thérapeutique du mésothéliome pleural malin en 2019
10. Oncogenèse pulmonaire: comprendre les addictions oncogéniques et les résistances
11. MA04.03 Osimertinib-induced Epigenetic and Transcriptional Reprogramming Drives a BRD4-POUF-PDGFRB-YAP-EMT Axis of Resistance in NSCLC
12. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGR
13. Les mutations des sites d’épissage de l’exon 14 de MET. Une nouvelle opportunité thérapeutique dans le cancer du poumon
14. Les cancers bronchiques non à petites cellules EGFR-mutés
15. The Po River Delta Epidemiological Survey: Reference Values of Total Serum IgE Levels in a Normal Population Sample of North Italy (8-78 yrs)
16. Algorithme thérapeutique des cancers bronchiques non à petites cellules étendus avec mutation de l’EGR: Therapeutic algorithm of EGFR mutation driven advanced non-small cell carcinoma
17. Oncogenèse pulmonaire : mécanismes généraux et addictions oncogéniques: Pulmonary oncogenesis: General mechanisms and oncogenic addictions
18. Issue 2 - “Update on adverse respiratory effects of indoor air pollution”. Part 2): Indoor air pollution and respiratory diseases: Perspectives from Italy and some other GARD countries
19. Respiratory/Allergic Symptoms in Italian Children Living Close to Cultivations Sprayed With Pesticides
20. Les cancers bronchiques non à petites cellules EGFR-mutés
21. Traitement des cancers bronchiques non à petites cellules de stades avancés mutés EGFR : quels inhibiteurs ? Quelles séquences thérapeutiques ?: EGFR mutation driven advanced non-small cell carcinoma: Which inhibitors? Which therapeutic sequences?
22. Oncogenèse pulmonaire : mécanismes généraux et addictions oncogéniques: Pulmonary oncogenesis: General mechanisms and oncogenic addictions
23. Genetic and environmental influences on infant anthropometry at birth and four months of life: evidence from singleton and twin data in the HEALS and earlyFOOD projects
24. Outdoor air pollution and respiratory health
25. Cancer bronchique
26. Allergy and asthma: Effects of the exposure to particulate matter and biological allergens
27. Single breath nitrogen test as predictor of lung function decline and COPD over an 8-year follow-up
28. Exposure to air pollution and allergic diseases in adults
29. Air pollution exposure and prevalence of chronic respiratory diseases in Italy
30. Influence of overweight/obesity, lifestyle and grey space on asthma in Italy
31. MA07.06 Eradicating Drug Tolerant Persisters (DTPs) In EGFR-Mutated Non Small Cell Lung Cancer (NSCLC) By Targeting TROP2
32. MA07.03 Systematic Engineering of TROP2 CAR T Cell Therapy to Overcome Resistance Pathways in EGFRmutant NSCLC
33. 1390P Clinical characteristics and treatment outcomes of patients with thoracic SMARCA4-deficient tumour
34. RItA: The Italian severe/uncontrolled asthma registry
35. 12-Month Follow-Up of Patients Included in the Italian Severe/Uncontrolled Asthma Registry (RItA)
36. Urban grey spaces are associated with increased allergy in the general population
37. Outdoor air pollution and respiratory diseases: A general update and an Italian perspective
38. 1341P NRAS mutated non-small cell lung cancer (NSCLC) patients: Characteristics and outcomes
39. Risk Factors for Chronic Obstructive Pulmonary Disease in a North Italian Rural Area
40. A Population-Based Study on the Influence of Agricultural and Grey Spaces Proximity on Biomarkers of Exposure and Effect
41. Serum Antibodies Anti-Benzo(a)Pyrene Diol Epoxide-DNA Adducts (BPDE-DNA) and Tobacco Smoking May Predict Respiratory Outcomes in a General Population Follow-Up
42. The severe asthma registries: a way to better know and fight the disease
43. Longitudinal Asthma Patterns in Italian Adult General Population Samples: Host and Environmental Risk Factors
44. Le cause ambientali delle patologie croniche dell’apparato respiratorio
45. Indoor air pollution, physical and comfort parameters related to schoolchildren's health: Data from the European SINPHONIE study
46. Efficacité et tolérance du lorlatinib en 2e ligne ou plus chez les patients, porteurs d’un cancer bronchique non à petites cellules (CBNPC) avancé ROS1+, traités dans le cadre d’une autorisation temporaire d’utilisation (ATU), étude IFCT-1803 LORLATU
47. Efficacité et tolérance du lorlatinib en 2e ligne ou plus chez les patients, porteurs d’un cancer bronchique non à petites cellules (CBNPC) avancé ALK+, traités dans le cadre d’une autorisation temporaire d’utilisation (ATU), étude IFCT-1803 LORLATU
48. The epidemiological link between ageing and respiratory diseases
49. 1349P Lorlatinib for advanced ROS1+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort
50. 1303P Lorlatinib for advanced ALK+ non-small cell lung cancer (NSCLC): Efficacy and safety data from IFCT-1803 LORLATU expanded access program (EAP) cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.